Nicholas Urbanski

Systemic Retinoids in Cutaneous T-Cell Lymphoma: A Scoping Review of Clinical Use and Evidence Gaps

Systemic retinoids are ubiquitously used in cutaneous T-cell lymphoma (CTCL), often in combination with skin-directed or systemic therapies, yet their role within contemporary multimodal treatment strategies has not been comprehensively synthesized. We conducted a PRISMA-ScR-guid...

New Annular, Indurated Plaques During Mogamulizumab Therapy in Cutaneous T‐Cell Lymphoma: A Clinicopathologic Pitfall

ABSTRACT New annular, indurated plaques arising during mogamulizumab therapy for cutaneous T‐cell lymphoma (CTCL) present a diagnostic challenge, as they may raise concern for treatment‐related eruption or disease progression. We report two patients with darker skin types who dev...